ArticleIndian journal of urology : IJU : journal of the Urological Society of India

ARASENS Trial: Should darolutamide now be added to androgen-deprivation therapy and docetaxel in patients with metastatic, hormone-sensitive prostate cancer?

Naveen KumarPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.